Healthcare · Biotechnology · NASDAQ
| Market cap | $26.38B |
|---|---|
| Trailing P/E | — |
| FCF yield | -4.0% |
| Revenue growth (YoY) | +66.7% |
| EPS growth (YoY) | — |
| FCF/share growth (YoY) | — |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
Insmed Incorporated trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →
| Member | Chamber | Trade | Amount | Disclosed |
|---|---|---|---|---|
| Josh Gottheimer | House | Sell | $1,001 - $15,000 | Jul 7, 2026 |
| Gilbert Cisneros | House | Sell | $1,001 - $15,000 | Nov 18, 2025 |
| Gilbert Cisneros | House | Sell | $1,001 - $15,000 | Oct 10, 2025 |
| Gilbert Cisneros | House | Sell | $1,001 - $15,000 | Sep 12, 2025 |
| Gilbert Cisneros | House | Sell | $1,001 - $15,000 | Aug 14, 2025 |
| Josh Gottheimer | House | Buy | $1,001 - $15,000 | Jul 16, 2025 |
| Josh Gottheimer | House | Sell | $1,001 - $15,000 | May 14, 2025 |
| Josh Gottheimer | House | Sell | $1,001 - $15,000 | Jul 9, 2024 |
| Josh Gottheimer | House | Sell | $1,001 - $15,000 | Jun 8, 2024 |